NRAS and colorectal carcinoma: Thereby, our study provides suggestive evidence that despite the use of large, multi-centric patient cohorts and powerful DL models, it is not possible to predict the mutational status of KRAS, NRAS, and PIK3CA from CRC histopathology slides with current methods.